REPOCEUTICALS A/S — Credit Rating and Financial Key Figures
CVR number: 36494433
Slotsmarken 12, 2970 Hørsholm
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | |||||
Costs of management | -1 200.51 | -1 369.70 | -1 722.44 | -2 240.33 | |
Employee benefit expenses | -65.00 | ||||
Other operating expenses | - 491.70 | -4 088.92 | -3 252.23 | -3 228.61 | |
Total depreciation | -1.78 | ||||
EBIT | - 558.48 | -1 200.51 | -5 458.62 | -4 974.66 | -5 468.94 |
Other financial expenses | - 112.27 | - 122.38 | - 378.93 | -67.23 | - 424.75 |
Pre-tax profit | - 670.75 | -1 322.89 | -5 837.55 | -5 041.89 | -5 893.69 |
Income taxes | 147.54 | 464.08 | 1 435.21 | 1 213.11 | 693.95 |
Net earnings | - 523.22 | - 858.80 | -4 402.35 | -3 828.78 | -5 199.74 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible rights | 6 976.28 | 8 867.62 | 7 292.01 | 6 805.02 | 6 318.03 |
Intangible assets total | 6 976.28 | 8 867.62 | 7 292.01 | 6 805.02 | 6 318.03 |
Other tangible assets | 320.54 | 113.36 | 101.86 | ||
Tangible assets total | 320.54 | 113.36 | 101.86 | ||
Other non-current investments | 365.99 | 647.13 | |||
Investments total | 365.99 | 647.13 | |||
Long term receivables total | |||||
Inventories total | 38.00 | 38.00 | |||
Prepayments and accrued income | 84.61 | 50.00 | 22.24 | 81.22 | |
Current other receivables | 120.19 | 260.03 | 512.25 | 379.22 | 691.85 |
Current deferred tax assets | 618.48 | 587.45 | 559.04 | 597.37 | 693.95 |
Short term receivables total | 823.27 | 847.49 | 1 121.29 | 998.83 | 1 467.02 |
Cash and bank deposits | 316.52 | 132.34 | 5 601.22 | 1 207.45 | 1 152.08 |
Cash and cash equivalents | 316.52 | 132.34 | 5 601.22 | 1 207.45 | 1 152.08 |
Balance sheet total (assets) | 8 154.08 | 9 885.45 | 14 335.06 | 9 490.66 | 9 686.12 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 560.00 | 560.00 | 896.13 | 896.13 | 896.13 |
Share premium account | 6 663.82 | 6 663.82 | |||
Other reserves | 5 504.85 | 6 651.25 | 5 413.86 | 4 074.23 | 3 920.35 |
Retained earnings | -6 163.74 | -7 833.35 | 10 132.87 | 7 158.78 | 3 221.70 |
Profit of the financial year | - 523.22 | - 858.80 | -4 402.35 | -3 828.78 | -5 199.74 |
Shareholders equity total | 6 041.72 | 5 182.91 | 12 040.52 | 8 300.36 | 2 838.44 |
Non-current leasing loans | 162.64 | 185.70 | 328.35 | ||
Provisions | 1 371.65 | 1 491.90 | 615.74 | ||
Non-current other liabilities | -2 743.30 | -2 983.81 | -1 231.48 | 5 170.19 | |
Non-current deferred tax liabilities | 1 371.65 | 1 491.90 | 615.74 | ||
Non-current liabilities total | 162.64 | 185.70 | 5 498.54 | ||
Current trade creditors | 597.18 | 565.11 | 469.56 | 711.40 | 816.75 |
Other non-interest bearing current liabilities | 143.53 | 2 645.52 | 1 046.60 | 293.20 | 532.38 |
Current liabilities total | 740.71 | 3 210.63 | 1 516.16 | 1 004.60 | 1 349.14 |
Balance sheet total (liabilities) | 6 782.43 | 8 393.54 | 13 719.32 | 9 490.66 | 9 686.12 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.